covid 19. Covid-19
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group will receive an identical propolis tablet (containing 300?mg Iranian green propolis) three times a day, before breakfast, lun
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: A willing to participate with written informed consent The diagnosis of coronavirus based on the PCR test.
Exclusion criteria
Exclusion criteria: Current use of warfarin Current use of Propolis Supplement Presence of sensitivity to bee products
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythrocyte Sedimentation Rate. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Severity and number of coughs. Timepoint: Day 1 and day 14. Method of measurement: Cough visual analogue scale (VAS).;Respiratory Rate. Timepoint: day 1 and day 14. Method of measurement: The number of breaths a person takes per minute.;Chest CT scan. Timepoint: Day 1 and day 14. Method of measurement: X ray imaging.;High-sensitivity C-reactive protein. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body temperature. Timepoint: Day 1 and day 14. Method of measurement: Clinical Thermometer.;Alanine aminotransferase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Aspartate aminotransferase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Superoxide dismutase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Albumin. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKarim Sohrabi
Esfahan University of Medical Sciences
Outcome results
None listed